Dermatitis due to substances taken internally

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 L27

Hospital discharge: ICD-9 693

Hospital discharge: excluded ICD-9 L272

Cause of death: ICD-10 L27

Cause of death: ICD-9 693

Cause of death: excluded ICD-9 L272

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

L12_INTERNALSUBSTANCEDERM

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 L20-L30

Name in latin Dermatitis e substantiis devoratis

↥

List of similar endpoints to Dermatitis due to substances taken internally based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

↥

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	1.76 [0.79, 3.90]	1.7e-1	110
15 years	0.01	2.00 [0.89, 4.48]	9.1e-2	99
5 years	0.00	4.29 [2.38, 7.74]	1.4e-6	57
1 year	0.00	8.75 [4.51, 16.96]	1.3e-10	21

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally
GWS hits: 0

↥

before Dermatitis due to substances taken internally
after Dermatitis due to substances taken internally

Loading survival analyses plot

Loading survival analyses table

↥